Targeting inflammatory demyelinating lesions to sites of wallerian degeneration

American Journal of Pathology

Volumn 171, Issue 5, 2007, Pages 1563-1575

  Tsunoda, Ikuo ^a   Tanaka, Tomoko ^a   Saijoh, Yukio ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; ENZYME LINKED IMMUNOSPOT ASSAY; HISTOPATHOLOGY; INFLAMMATORY CELL; MOUSE; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RICINUS COMMUNIS;

EID: 36349002847     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070147     Document Type: Article

References (62)

1. Legido A, Tenembaum SN, Katsetos CD, Menkes JH: Autoimmune and postinfectious diseases. Child Neurology, ed 7. Edited by JH Menkes, HB Sarnat, BL Maria. Philadelphia, Lippincott Williams & Wilkins, 2006, pp 557-657
2. Silber E, Sharief MK: Axonal degeneration in the pathogenesis of multiple sclerosis. J Neurol Sci 1999, 170:11-18
3. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278-285
4. Ferguson B, Matyszak MK, Esiri MM, Perry VH: Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120:393-399
5. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W: Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002, 125:2202-2212
6. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W: Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000, 123:1174-1183
7. Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD: Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 2001, 57:1248-1252
8. Sharma R, Narayana PA, Wolinsky JS: Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler 2001, 7:221-226
9. Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, Arnold DL: Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 1998, 18:327-336
10. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S: Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000, 123:308-317
11. Dandekar AA, Perlman S: Axons and neurons in coronavirus-induced demyelination. Experimental Models of Multiple Sclerosis. Edited by E Lavi, CS Constantinescu. New York, Springer Science and Business Media, Inc., 2005, pp 737-745
12. Tsunoda I, Fujinami RS: Inside-out versus outside-in models for virus induced demyelination: axonal damage trigger demyelination. Springer Semin Immunopathol 2002, 24:105-125
13. Kuhn MJ, Johnson KA, Davis KR: Wallerian degeneration: evaluation with MR imaging. Radiology 1988, 168:199-202
14. Henry RG, Oh J, Nelson SJ, Pelletier D: Directional diffusion in relapsing-remitting multiple sclerosis: a possible in vivo signature of Wallerian degeneration. J Magn Reson Imaging 2003, 18:420-426
15. Sawlani V, Gupta RK, Singh MK, Kohli A: MRI demonstration of Wallerian degeneration in various intracranial lesions and its clinical implications. J Neurol Sci 1997, 146:103-108
16. Simon JH, Kinkel RP, Jacobs L, Bub L, Simonian N: A Wallerian degeneration pattern in patients at risk for MS. Neurology 2000, 54:1155-1160
17. Werring DJ, Brassat D, Droogan AG, Clark CA, Symms MR, Barker GJ, MacManus DG, Thompson AJ, Miller DH: The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000, 123:1667-1676
18. De Stefano N, Narayanan S, Matthews PM, Francis GS, Antel JP, Arnold DL: In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 1999, 122:1933-1939
19. Adams RD, Kubik CS: The morbid anatomy of the demyelinative diseases. Am J Med 1952, 12:510-546
20. Tsunoda I, Fujinami RS: Theiler's murine encephalomyelitis virus. Persistent Viral Infections. Edited by R Ahmed, I Chen. Chichester, John Wiley & Sons, Ltd., 1999, pp 517-536
21. Ulrich R, Baumgärtner W, Gerhauser I, Seeliger F, Haist V, Deschl U, Alldinger S: MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating Theiler's murine encephalomyelitis. J Neuropathol Exp Neurol 2006, 65:783-793
22. Rivera-Quiñones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M: Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med 1998, 4:187-193
23. Tsunoda I, Tolley ND, Theil DJ, Whitton JL, Kobayashi H, Fujinami RS: Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol 1999, 9:481-493
24. Tsunoda I, Kuang L-Q, Libbey JE, Fujinami RS: Axonal injury heralds virus-induced demyelination. Am J Pathol 2003, 162:1259-1269
25. Ure DR, Rodriguez M: Histopathology in the Theiler's virus model of demyelination. Experimental Models of Multiple Sclerosis. Edited by E Lavi, CS Constantinescu. New York, Springer, 2005, pp 579-591
26. Zipp F, Aktas O: The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 2006, 29:518-527
27. Tsunoda I, Kuang L-Q, Igenge IZM, Fujinami RS: Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. J Neuroimmunol 2005, 160:122-134
28. Tsunoda I, Terry EJ, Marble BJ, Lazarides E, Woods C, Fujinami RS: Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade. Brain Pathol 2007, 17:45-55
29. Tsunoda I, Wada Y, Libbey JE, Cannon TS, Whitby FG, Fujinami RS: Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol 2001, 75:7494-7505
30. + T-cell clones following virus infection. J Virol 2005, 79:14640-14646
31. Tsunoda I, Lane TE, Blackett J, Fujinami RS: Distinct roles for IP-10/CXCL10 in three animal models. Theiler's virus infection EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. Mult Scler 2004, 10:26-34
32. Tsunoda I, Kuang L-Q, Tolley ND, Whitton JL, Fujinami RS: Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol 1998, 57:758-767
33. Yamamoto T, Iwasaki Y, Konno H: Retrograde axoplasmic transport of toxic lectins is useful for transganglionic tracings of the peripheral nerve. Brain Res 1983, 274:325-328
34. Yamamoto T, Iwasaki Y, Konno H: Experimental sensory ganglionectomy by way of suicide axoplasmic transport. J Neurosurg 1984, 60:108-114
35. Yamamoto T, Iwasaki Y, Konno H, Kudo H: Primary degeneration of motor neurons by toxic lectins conveyed from the peripheral nerve. J Neurol Sci 1985, 70:327-337
36. Gehrmann J, Gold R, Linington C, Lannes-Vieira J, Wekerle H, Kreutzberg GW: Spinal cord microglia in experimental allergic neuritis. Evidence for fast and remote activation. Lab Invest 1992, 67:100-113
37. Smith KJ, Bennett BJ: Topographic and quantitative description of rat dorsal column fibres arising from the lumbar dorsal roots. J Anat 1987, 153:203-215
38. Dal Canto MC, Vanderlugt CL: The role of astrocytes, oligodendrocytes, microglia and endothelial cells in TMEV infection. Experimental Models of Multiple Sclerosis. Edited by E Lavi, CS Constantinescu. New York, Springer, 2005, pp 617-628
39. Upton HL, Kumar ASM, Trottier M: Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes. Virus Res 2005, 111: 214-223
40. Takács K, Chandler P, Altmann DM: Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Eur J Immunol 1997, 27:2927-2934
41. Tsunoda I, Tanaka T, Terry EJ, Fujinami RS: Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: when can axonal injury be beneficial? Am J Pathol 2007, 170:214-226
42. Konno H, Yamamoto T, Suzuki H, Yamamoto H, Iwasaki Y, Ohara Y, Terunuma H, Harata N: Targeting of adoptively transferred experimental allergic encephalitis lesion at the sites of Wallerian degeneration. Acta Neuropathol (Berl) 1990, 80:521-526
43. Molleston MC, Thomas ML, Hickey WF: Novel major histocompatibility complex expression by microglia and site-specific experimental allergic encephalomyelitis lesions in the rat central nervous system after optic nerve transection. Adv Neurol 1993, 59:337-348
44. Pelletier D, Nelson SJ, Oh J, Antel JP, Kita M, Zamvil SS, Goodkin DE: MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy. J Neurol Neurosurg Psychiatry 2003, 74:950-952
45. Vallières N, Berard JL, David S, Lacroix S: Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 2006, 53:103-113
46. Finsen B, Jensen MB, Lomholt ND, Hegelund IV, Poulsen FR, Owens T: Axotomy-induced glial reactions in normal and cytokine transgenic mice. Adv Exp Med Biol 1999, 468:157-171
47. Garrison CJ, Dougherty PM, Kajander KC, Carlton SM: Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 1991, 565:1-7
48. Raghavendra V, Tanga FY, DeLeo JA: Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 2004, 20:467-473
49. Sweitzer SM, Colburn RW, Rutkowski M, DeLeo JA: Acute peripheral inflammation induces moderate glial activation and spinal IL-18 expression that correlates with pain behavior in the rat. Brain Res 1999, 829:209-221
50. Watkins LR, Maier SF: Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 2005, 257:139-155
51. Abbott NJ, Rönnbäck L, Hansson E: Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53
52. Huber JD, Witt KA, Horn S, Egleton RD, Mark KS, Davis TP: Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am J Physiol 2001, 280:H1241-H1248
53. van Hooft JA: Fast Green FCF (Food Green 3) inhibits synaptic activity in rat hippocampal interneurons. Neurosci Lett 2002, 318:163-165
54. Yoshida M, Nagatsuka Y, Muramatsu S, Niijima K: Differential roles of the caudate nucleus and putamen in motor behavior of the cat as investigated by local injection of GABA antagonists. Neurosci Res 1991, 10:34-51
55. Simmons RD, Willenborg DO: Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J Neurol Sci 1990, 100:37-42
56. Sethna MP, Lampson LA: Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-γ. J Neuroimmunol 1991, 34:121-132
57. Phillips LM, Lampson LA: Site-specific control of T cell traffic in the brain: T cell entry to brainstem vs. hippocampus after local injection of IFN-γ. J Neuroimmunol 1999, 96:218-227
58. Clark G, Bogdanove LH: The induction of the lesions of allergic meningoencephalomyelitis in a predetermined location. J Neuropathol Exp Neurol 1955, 14:433-437
59. Levine S, Hoenig EM: Induced localization of allergic adrenalitis and encephalomyelitis at sites of thermal injury. J Immunol 1968, 100:1310-1318
60. Kerschensteiner M, Stadelmann C, Buddeberg BS, Merkler D, Bareyre FM, Anthony DC, Linington C, Brück W, Schwab ME: Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol 2004, 164:1455-1469
61. Sun D, Newman TA, Perry VH, Weller RO: Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis. Neuropathol Appl Neurobiol 2004, 30:374-384
62. Kira J: Multiple sclerosis in the Japanese population. Lancet Neurol 2003, 2:117-127